| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/25/2004 | US6740794 Skewing percentage of females to males in shrimp or prawn |
| 05/25/2004 | US6740751 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 05/25/2004 | US6740748 Developmental regulation in anther tissue of plants |
| 05/25/2004 | US6740744 VMP-like sequences of pathogenic borrelia |
| 05/25/2004 | US6740743 Biosynthesis of polynucleotides using amplification primers |
| 05/25/2004 | US6740740 Process for isolating and purifying proteins and peptides from plant sources |
| 05/25/2004 | US6740739 Substitutional variants of APO-2 ligand |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740736 Purification of fibrinogen from milk by use of cation exchange chromatography |
| 05/25/2004 | US6740735 Hypertriglyceridemia |
| 05/25/2004 | US6740734 Bacterial receptor structures |
| 05/25/2004 | US6740638 Amino acid sequence has 87-99 peptide residues |
| 05/25/2004 | US6740525 Adenoviral capsid containing chimeric protein IX |
| 05/25/2004 | US6740524 A phage expressing a bi-functional protein with a nuclear translocation and cell adhesion activities; used to package a foreign substance such as a gene, and in gene therapy |
| 05/25/2004 | US6740523 Administering 14-3-3 sigma protein for suppressing growth of tumor cells |
| 05/25/2004 | US6740522 Rank (receptor activator of neurotrophic factor-kappa b) ligand (rankl) polypeptides; immunoregulatory activity |
| 05/25/2004 | US6740520 Cytokine receptor and nucleic acids encoding the same |
| 05/25/2004 | US6740511 Comprising mutations at one or more residues within the region of fiber stretching; used in gene therapy |
| 05/25/2004 | US6740509 Method for the production of mucin-type glycopeptide |
| 05/25/2004 | US6740507 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 05/25/2004 | US6740506 End selection in directed evolution |
| 05/25/2004 | US6740504 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 05/25/2004 | US6740494 Nuclear matrix protein fluid assay |
| 05/25/2004 | US6740490 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with cd antigens; animal husbandry |
| 05/25/2004 | US6740488 Cotton event PV-GHGT07(1445) compositions and methods for detection thereof |
| 05/25/2004 | US6740487 Variant TLR4 nucleic acid and uses thereof |
| 05/25/2004 | US6740486 Nucleic acid and polypeptide p10 of a Borna Disease virus (BDV) and their use for diagnostic and immunization purposes |
| 05/25/2004 | US6740485 Identification of genes responsible for the virulence of staphylococcus bacteria, which allows for identification of new anti-bacterial agents and mutants that can be used as vaccines |
| 05/25/2004 | US6740324 Modified cytomegalovirus, the modifications include adding heterologus sequence enconding a non-viral chemokine element and/or immunogenic polypeptide, and/or diabling a viral dissemination gene |
| 05/25/2004 | US6740323 HBV/HCV virus-like particle |
| 05/25/2004 | US6740322 Immunization of dairy cattle with Mig protein |
| 05/25/2004 | US6740320 Recombinant P53 adenovirus methods and compositions |
| 05/25/2004 | CA2278782C Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 05/25/2004 | CA2260795C Synthetic protein folding catalysis |
| 05/25/2004 | CA2176745C Nucleic acid analogs with a chelating functionality |
| 05/25/2004 | CA2112096C Dna sequences of the human papillomavirus type 42 and diagnostic application thereof |
| 05/21/2004 | WO2004042402A2 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 05/21/2004 | WO2004042361A2 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 05/21/2004 | WO2004042358A2 HUMAN TYPE II DIABETES GENE-SLIT-3 LOCATED ON CHROMOSOME 5q35 |
| 05/21/2004 | WO2004042352A2 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| 05/21/2004 | WO2004042350A2 Using amines or amino acids as mobile phase modifiers in chromatography |
| 05/21/2004 | WO2004042345A2 Bacterial small-molecule three-hybrid system |
| 05/21/2004 | WO2004042075A2 Inactivated ga1 - nac - transferases, methods for inhibitors of such transferases and their use |
| 05/21/2004 | WO2004042071A2 Detection and typing of human papillomavirus using pna probes |
| 05/21/2004 | WO2004042063A1 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 05/21/2004 | WO2004042060A1 Method of immobilising a protein to a zeolite |
| 05/21/2004 | WO2004042056A1 Physiologically active polypeptide and its antibody and use thereof |
| 05/21/2004 | WO2004042043A2 Crystal structures of bacterial ribulose-phosphate 3-epimerases |
| 05/21/2004 | WO2004042042A1 Vaccines against west nile virus |
| 05/21/2004 | WO2004042040A1 Expansion agents for stem cells |
| 05/21/2004 | WO2004042037A1 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 05/21/2004 | WO2004042035A2 Organic anion transport polypeptide related protein-4 (oatprp4) gene in tourette syndrome and related disorders |
| 05/21/2004 | WO2004042031A2 Safer attenuated virus vaccines with missing or diminished latency of infection |
| 05/21/2004 | WO2004042026A2 NUCLEIC ACID AND ALLERGENIC POLYPEPTIDES ENCODED THEREBY IN CASHEW NUTS (Anacardium occidentale) |
| 05/21/2004 | WO2004042025A2 Cell-specific adenovirus vector comprising ebv-specific promoter |
| 05/21/2004 | WO2004042004A2 Mouse model for autoimmune disorders |
| 05/21/2004 | WO2004042001A2 Virus-like particles, methods of preparation, and immonogenic compositions |
| 05/21/2004 | WO2004042000A2 157 human secreted proteins |
| 05/21/2004 | WO2004041999A2 No-apical meristem proteins, polynucleotides and methods of use for same |
| 05/21/2004 | WO2004041997A2 Immunotherapy regimens in hiv-infected patients |
| 05/21/2004 | WO2004041861A2 Alpha macroglobulin family member |
| 05/21/2004 | WO2004041860A1 Icam-4 binding sites |
| 05/21/2004 | WO2004041859A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/21/2004 | WO2004041858A2 Improving growth characteristics of filamentous microorganisms |
| 05/21/2004 | WO2004041857A2 Mutant of clostridium difficile toxin b and methods of use |
| 05/21/2004 | WO2004041855A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis |
| 05/21/2004 | WO2004041854A2 Essential novel bacterial polypeptides |
| 05/21/2004 | WO2004041853A2 Hcv vaccine compositions comprising e1 and ns3 peptides |
| 05/21/2004 | WO2004041852A2 Hiv vaccine |
| 05/21/2004 | WO2004041851A2 Vaccine |
| 05/21/2004 | WO2004041850A1 Novel fprl1 ligands and use thereof |
| 05/21/2004 | WO2004041849A1 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
| 05/21/2004 | WO2004041845A2 Templated native silk smectic gels |
| 05/21/2004 | WO2004041843A2 Hop - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification |
| 05/21/2004 | WO2004041842A2 Epitopes of hepatitis c virus |
| 05/21/2004 | WO2004041779A2 Amyloid plaque formation by glycosaminoglycans |
| 05/21/2004 | WO2004041297A2 Modified cytokines for use in cancer therapy |
| 05/21/2004 | WO2004041216A2 Ptpn11 (shp-2) mutations and cancer |
| 05/21/2004 | WO2004041205A2 Ha4, a new osteoblast- and chondrocyte-specific small secreted peptide, compositions and methods of use |
| 05/21/2004 | WO2004041182A2 M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever |
| 05/21/2004 | WO2004041179A2 Scavenger receptor b1 (cla-1) targeting for the treatment of infection, sepsis and inflammation |
| 05/21/2004 | WO2004041172A2 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | WO2004041170A2 Compositions and methods for the treatment of immune related diseases |
| 05/21/2004 | WO2004041160A2 Methods and animal model for analyzing age-related macular degeneration |
| 05/21/2004 | WO2004041152A2 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl |
| 05/21/2004 | WO2004041151A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 05/21/2004 | WO2004041076A2 Methods of detecting colorectal cancer |
| 05/21/2004 | WO2004040970A1 Model animal of human hematopoietic organ tumor |
| 05/21/2004 | WO2004027066A3 Chimeric recombinant protein and in vitro diagnosis of hiv |
| 05/21/2004 | WO2004027020A9 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 05/21/2004 | WO2004024925A8 Collectin-complement activating protein chimeras |
| 05/21/2004 | WO2004024087A9 Methods of diagnosing and treating hyperproliferative disorders |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | WO2004019872A3 Oral delivery of modified transferrin fusion proteins |
| 05/21/2004 | WO2004018629A8 Stars-a muscle-specification-binding protein |
| 05/21/2004 | WO2004016652A3 Mammaglobin promoter |
| 05/21/2004 | WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 05/21/2004 | WO2004003153A9 Live replicating spumavirus vector |
| 05/21/2004 | WO2004000032A3 Colour reduction in canola protein isolate |
| 05/21/2004 | WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |